ECS Botanics Holdings Ltd (ASX: ECS)
Health Care · Pharmaceuticals · AU
AU$0.01
-16.67% today · -33.3% 1Y
ECS Botanics Holdings Ltd (ASX: ECS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.72M and employs 220 people.
Over the last twelve months the share price has lost 33.3%, trading between 0.00 and 0.01.
Tweenvest scores ECS Botanics Holdings Ltd across four factors: quality 55/100, value 65/100, growth 100/100. Its strongest factor is growth.
ECS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.72M
- Revenue (TTM)
- $13.99M
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 1.14
- 52-week high
- AU$0.01
- 52-week low
- AU$0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.60B
- Employees
- 220
- Next earnings
- —
About ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd specializes in the cultivation, processing, and commercialization of medicinal cannabis products. The enterprise also markets a variety of hemp-derived wellness and food items and is active in the agricultural sector. Its primary operations are headquartered in Launceston, Australia.
- ISIN
- AU0000052490
- Listed since
- Jan 2, 2000
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.00 | -0.07% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.00 | -0.75% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.75 | +0.06% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.00 | +0.16% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.66 | +0.46% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.89 | -0.29% |
Figures last refreshed Aug 18, 2026.